发明名称 |
CRYSTALLINE PHARMACEUTICALLY ACTIVE INGREDIENTS |
摘要 |
The present invention is related to crystalline forms of rosuvastatin zinc (2:1) salt. The polymorphs are suitable for use as pharmaceutically active ingredients in the treatment of the diseases of the lipid metabolism including hypercholesterolemia, hyperlipidemia, dyslipidemia or atherosclerosis.
|
申请公布号 |
US2013296353(A1) |
申请公布日期 |
2013.11.07 |
申请号 |
US201113885509 |
申请日期 |
2011.11.16 |
申请人 |
MARKOVITS IMRE;JURAK FERENC;KOVANYINE LAX GYORGYI;HAMORI CSABA;HAVASI BALAZS;SIPOS EVA;VOLK BALAZS;RUNGE ZSOLT;FODORNE KOCSMAR KRISZTINA;LUKACS GYULA;KATAINE FADGYAS KATALIN;MEZOVARI MONIKA;EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTAR- SASAG |
发明人 |
MARKOVITS IMRE;JURAK FERENC;KOVANYINE LAX GYORGYI;HAMORI CSABA;HAVASI BALAZS;SIPOS EVA;VOLK BALAZS;RUNGE ZSOLT;FODORNE KOCSMAR KRISZTINA;LUKACS GYULA;KATAINE FADGYAS KATALIN;MEZOVARI MONIKA |
分类号 |
C07D239/42 |
主分类号 |
C07D239/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|